Belgian Infusions SRL
Belgian Infusions reported total assets of €1.53m at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Sep 2026).
The score of Belgian Infusions shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +1066 % Total assets +647 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Belgian Infusions's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 376,510 € | ||||
| Equity | 629,711 € | ||||
| Cash | 14,161 € | ||||
| EBITDA | 580,763 € | ||||
| Total assets | €1.53m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Sep 2026
- Year ended 31 Dec 2024filed on 09 Oct 2025
- Year ended 31 Dec 2023filed on 26 Aug 2024
- Year ended 31 Dec 2022filed on 26 Sep 2023
- Year ended 31 Dec 2021filed on 11 Aug 2022
Belgian Infusions's financial analysis
- Solvency41.2%sector median: 43.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Belgian Infusions
Belgian Infusions's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0759.731.813
- VAT number
- BE0759731813
- Peppol
- Registered · 0208:0759731813 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 14 Dec 2020
- Registered office
- 7060 Soignies
- Latest accounts
- 2025 · filed on 30 Sep 2026
- Activity
- Manufacture of other chemical products n.e.c. (NACE 20590)
Belgian Infusions (SRL) has been based in Soignies since 2020, active in: manufacture of other chemical products n.e.c.. For 2025, it reports a net profit of 376,510 € and equity of 629,711 €; its revenue is not published. Its solvency stands at 41.2%, below the median of its sector (43.8%).
Companies similar to Belgian Infusions
Companies in the same business, of comparable size and area, outside its group.
- Guirec Business and other management consultancy activities Rixensart · balance sheet 904,336 €
- Higeja Business and other management consultancy activities Heuvelland · balance sheet 315,233 €
- Ronami Business and other management consultancy activities Pelt · balance sheet 746,540 €
- Vistradex Business and other management consultancy activities Boechout · balance sheet €1.01m
- JOKA Business and other management consultancy activities Lier · balance sheet 829,839 €
- Span74 Business and other management consultancy activities Ghent · balance sheet 585,896 €
- TM Consulting Business and other management consultancy activities Antwerp · balance sheet 503,875 €
- I & P Consulting Business and other management consultancy activities Hasselt · balance sheet €5.96m
Frequently asked questions about Belgian Infusions
What is the revenue of Belgian Infusions?
Belgian Infusions files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Belgian Infusions?
In Belgium, the VAT number is the company number prefixed with BE: BE0759731813 for Belgian Infusions, if the company is VAT-registered. Its company number (CBE) is 0759.731.813.
Where is the registered office of Belgian Infusions?
According to the CBE register, the registered office of Belgian Infusions is in 7060 Soignies.
What is the equity of Belgian Infusions?
At the close of the 2025 financial year, the equity of Belgian Infusions amounts to 629,711 €, a solvency of 41.2% of total assets.
Who manages Belgian Infusions?
The register lists 1 active mandates at Belgian Infusions. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Belgian Infusions
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →